These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 4683425

  • 1. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS.
    Glader BE, Conrad ME.
    J Lab Clin Med; 1973 Feb; 81(2):267-72. PubMed ID: 4683425
    [No Abstract] [Full Text] [Related]

  • 2. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells.
    Scott GL, Rasbridge MR.
    Br J Haematol; 1973 Mar; 24(3):307-17. PubMed ID: 4713632
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of ethanol on the detoxification of hydrogen peroxide induced by ascorbic acid in normal erythrocytes and those with glucose-6-phosphate dehydrogenase deficiency].
    Coutinho V.
    Sangre (Barc); 1984 Mar; 29(1):10-4. PubMed ID: 6719314
    [No Abstract] [Full Text] [Related]

  • 4. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
    Grossman S, Budinsky R, Jollow D.
    J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
    [Abstract] [Full Text] [Related]

  • 5. Two mechanisms for toxic effects of hydroxylamines in human erythrocytes: involvement of free radicals and risk of potentiation.
    Evelo CT, Spooren AA, Bisschops RA, Baars LG, Neis JM.
    Blood Cells Mol Dis; 1998 Sep; 24(3):280-95. PubMed ID: 10087986
    [Abstract] [Full Text] [Related]

  • 6. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
    Reilly TP, Woster PM, Svensson CK.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced hemolysis: biochemical considerations.
    Shahidi NT.
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
    [No Abstract] [Full Text] [Related]

  • 8. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
    Dziewulska KH, Reisz JA, Hay AM, D'Alessandro A, Zimring JC.
    J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
    [Abstract] [Full Text] [Related]

  • 9. A study on the interaction between hydroxylamine analogues and oxyhemoglobin in intact erythrocytes.
    Spooren AA, Evelo CT.
    Blood Cells Mol Dis; 2000 Aug; 26(4):373-86. PubMed ID: 11042038
    [Abstract] [Full Text] [Related]

  • 10. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
    Bashan N, Peleg N, Moses SW.
    Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
    [No Abstract] [Full Text] [Related]

  • 11. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver.
    Ciccoli L, Ferrali M, Rossi V, Signorini C, Alessandrini C, Comporti M.
    Toxicol Lett; 1999 Oct 29; 110(1-2):57-66. PubMed ID: 10593595
    [Abstract] [Full Text] [Related]

  • 12. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
    Magon A, Leipzig RM, Bloom K, Brewer GJ.
    Prog Clin Biol Res; 1981 Oct 29; 55():709-24. PubMed ID: 7291202
    [Abstract] [Full Text] [Related]

  • 13. Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver.
    Veggi LM, Pretto L, Ochoa EJ, Catania VA, Luquita MG, Taborda DR, Sánchez Pozzi EJ, Ikushiro S, Coleman MD, Roma MG, Mottino AD.
    Life Sci; 2008 Aug 01; 83(5-6):155-63. PubMed ID: 18602405
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells.
    Albuquerque RV, Malcher NS, Amado LL, Coleman MD, Dos Santos DC, Borges RS, Valente SA, Valente VC, Monteiro MC.
    PLoS One; 2015 Aug 01; 10(8):e0134768. PubMed ID: 26284371
    [Abstract] [Full Text] [Related]

  • 16. Erythrocyte glutathione peroxidase deficiency. Biochemical studies on the mechanisms of drug-induced hemolysis.
    Steinberg MH, Necheles TF.
    Am J Med; 1971 Apr 01; 50(4):542-6. PubMed ID: 5572598
    [No Abstract] [Full Text] [Related]

  • 17. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
    Grossman SJ, Jollow DJ.
    J Pharmacol Exp Ther; 1988 Jan 01; 244(1):118-25. PubMed ID: 3335994
    [Abstract] [Full Text] [Related]

  • 18. A methemoglobin-dependent and plasma-stimulated experimental model of oxidative hemolysis.
    Benatti U, Morelli A, Damiani G, De Flora A.
    Biochem Biophys Res Commun; 1982 Jun 30; 106(4):1183-90. PubMed ID: 6810891
    [No Abstract] [Full Text] [Related]

  • 19. Effects of some metabolites of hemolytic drugs on young and old, normal and G-6-PD-deficient human erythrocytes.
    Fraser IM, Tilton BE, Vesell ES.
    Ann N Y Acad Sci; 1971 Jul 06; 179():644-53. PubMed ID: 5285395
    [No Abstract] [Full Text] [Related]

  • 20. Procabazine induced oxidative haemolysis: relationship in vivo red cell survival.
    Sponzo RW, Arseneau JC, Canellos GP.
    Br J Haematol; 1974 Aug 06; 27(4):587-95. PubMed ID: 4417500
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.